Authors


Cathaleen Madsen, PhD

Latest:

An Integrated Practice Unit Tool for the Military Health System

Researchers developed and tested an assessment tool to measure coordinated care for traumatic brain injury against the criteria of an integrated practice unit.


Thomas Ollis, MS, RPh

Latest:

The Impact of Evolving Treatment Options in Multiple Myeloma, Part 10

Bruce A. Feinberg, DO; Ryan Haumschild, PharmD, MS, MBA; Thomas Ollis, MS, RPh; and Joseph Mikhael, MD, discuss the future treatment landscape for the management of multiple myeloma.


Bich Ly, BA

Latest:

Commercial and Medicare Advantage Payment for Anesthesiology Services

Mean in-network commercial allowed amounts and charges per anesthesia conversion factor are 314% and 659% of traditional Medicare rates, respectively. Medicare Advantage payments align with traditional Medicare prices.


Alexis Ogdie, MD, MSCE

Latest:

Association of Physician Specialty With Psoriatic Arthritis Treatment and Costs

In this retrospective cohort study of patients with newly diagnosed psoriatic arthritis, the authors examine the association of treatment selection and costs with physician specialty.



Fang Sun, MD, PhD

Latest:

Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies

Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.


Sauradeep Sarkar, MD

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Amy Freeman, LPN

Latest:

Leveraging Longitudinal Clinical Laboratory Results to Improve Prenatal Care

Collaboration between a clinical laboratory and a managed care organization improved prenatal care and outcomes through real-time, actionable, laboratory-derived insights and care coordination.


Neli P. Ragina, PhD

Latest:

Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.


Julie B. Schnur, PhD

Latest:

Physician Preferences for an Electronic Lung Cancer Screening Decision Aid

This qualitative study on primary care physicians yielded suggestions that can inform the design of an effective lung cancer screening decision aid tool and implementation into the electronic health record.


Anthony Bonagura, MD

Latest:

Assessing the Impact of Transplant Case Management on Clinical Outcomes

This article examines the effect of a transplant case management program on clinical outcomes following transplant surgery.


Qin Chen, MS

Latest:

How Do Primary Community Hospitals Enact Early Response to COVID-19? The Experience From Chengdu, China

Our hospital is a primary hospital in Chengdu, China. Since February 5, our hospital has been listed as the primary designated medical unit for treating new patients with coronavirus disease 2019 (COVID-19) in Jinniu District. In this letter, we share our COVID-19 experience with readers.


Rick Chapman, PhD
Rick Chapman, PhD

Latest:

Contributor: The Role of Dynamic Pricing in Health Technology Assessment for MDD

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.


Dellara F. Terry, MD, MPH

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


Ayesha Ahmed, PharmD

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.


Soni Gupta, MEc

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.


Mary Dittrich, MD

Latest:

Caring for Individuals With Kidney Disease During the Pandemic

Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.


Ashwini Davison, MD

Latest:

Implementation and Cost Validation of a Real-time Benefit Tool

This study evaluates impact of a real-time benefit tool on medication access and physician and pharmacy workflows at a large academic medical center.


Si Xuan, PhD

Latest:

Medication Persistence and Its Impact on Type 2 Diabetes

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.


John K. Cuddeback, MD, PhD

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Jean-Pierre Llanos, MD

Latest:

Clinical and Economic Burden of Uncontrolled Severe Noneosinophilic Asthma

Among patients with severe asthma with low eosinophils untreated with biologics, there is a high burden of disease among those who have suboptimal disease control.



Elizabeth L. Ciemins, PhD, MPH, MA

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Carl B. Abbott, PharmD

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.


Marco Meglio

Latest:

EU Approves Self-Administered Rozanolixizumab for Myasthenia Gravis

With 2 new self-administration methods, patients living with generalized myasthenia gravis can be more empowered to manage their treatment with greater independence and control.


Frank J. Palella, MD

Latest:

Key Takeaways for the Management of HIV PrEP

A panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.


Zhigang Xie, PhD, MPA

Latest:

Hospitalization Patterns Among Older Patients With Cancer With and Without Dementia

Dementia was more prevalent in older patients with some cancer types, and comorbid dementia in this population was associated with unplanned or unnecessary hospitalization.


Jeff McPheeters, BA

Latest:

Health Care Costs Associated With Unrecognized Progression to Late-Stage Kidney Disease

Unrecognized disease progression is associated with higher health care costs both for patients with end-stage kidney disease and late-stage (stages G4-G5) chronic kidney disease.


Aaron L. Schwartz, MD, PhD

Latest:

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.


Lana Pine

Latest:

Clinical Disease Control in Psoriatic Arthritis Improves Quality of Life

Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo